• Iqbal M Fahs, Souheil Hallit, Mohamad K Rahal, and Diana N Malaeb.
• School of Pharmacy, Lebanese International University, Mouseitbah, Lebanon.
• Med Princ Pract. 2018 Jan 1; 27 (6): 508514508-514.

ObjectiveTo assess the role of the pharmacist in modifying risk factors for cardiovascular disease (CVD) among Lebanese adults in urban and rural areas.MethodsIn a prospective survey, 865 out of 1,000 participants aged ≥45 years, previously interviewed, agreed to be followed at 1 and 2 years time points. Parameters including blood pressure, lipid profile, blood glucose, average number of risk factors, and atherosclerotic CVD (ASCVD) risk were assessed and evaluated at the beginning of the study, then after 1 and 2 years.ResultsDuring both follow-ups, the mean average body mass index and systolic blood pressure decreased significantly and the lipid profile improved significantly. Further significant improvements in ASCVD risk occurred during the second follow-up. Monitoring parameters revealed significant improvements as well.ConclusionThis study showed that a plan that includes pharmacists, who regularly monitor and follow-up patients, could improve CVD prevention through the reduction of risk factors.©2018The Author(s) Published by S. Karger AG, Basel.

30 keywords...

hide…